Evaluation of the Pharmacokinetic Features and Tissue Distribution of the Potent Nonnucleoside Inhibitor of HIV-1 Reverse Transcriptase, N-[2-(2-fluorophenethyl)]-N′-[2-(5-bromopyridyl)]-thiourea (HI-240) with an Analytical HPLC Method

@article{Chen2004EvaluationOT,
  title={Evaluation of the Pharmacokinetic Features and Tissue Distribution of the Potent Nonnucleoside Inhibitor of HIV-1 Reverse Transcriptase, N-[2-(2-fluorophenethyl)]-N′-[2-(5-bromopyridyl)]-thiourea (HI-240) with an Analytical HPLC Method},
  author={C. Chen and F. Uckun},
  journal={Pharmaceutical Research},
  year={2004},
  volume={16},
  pages={1226-1232}
}
  • C. Chen, F. Uckun
  • Published 2004
  • Medicine, Chemistry
  • Pharmaceutical Research
  • AbstractPurpose. The purpose of the present study was to examine the pharmacokinetic features and tissue distribution of N-[2-(2-fluorophenethyl)]-N′-[2-(5-bromopyridyl)]-thiourea (HI-240), a novel non-nucleoside inhibitor of HIV reverse transcriptase with potent anti-viral activity against AZT-sensitive as well as multidrug-resistant HIV-1 strains. Methods. A sensitive and accurate high performance liquid chromatography (HPLC)-based quantitative detection method was established to measure… CONTINUE READING
    7 Citations
    Novel tight binding PETT, HEPT and DABO-based non-nucleoside inhibitors of HIV-1 reverse transcriptase
    • O. D'cruz, F. Uckun
    • Biology, Medicine
    • Journal of enzyme inhibition and medicinal chemistry
    • 2006
    • 22
    Effect of stereochemistry on the anti-HIV activity of chiral thiourea compounds.
    • 112
    Dawn of non-nucleoside inhibitor-based anti-HIV microbicides.
    • 96
    • PDF

    References

    SHOWING 1-10 OF 10 REFERENCES
    Tissue distribution and metabolic disposition of zidovudine in rats.
    • 40
    A TOXICOLOGIC STUDY OF DIMETHYL SULFOXIDE.
    • 84
    Physiological Parameters in Laboratory Animals and Humans
    • 2,178